Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31776 - 31800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	LAMA3	3909	upregulated	Cisplatin results in increased expression of LAMA3 mRNA	18q11.2	A20427
Cisplatin	Approved Investigational	LARS	51520	downregulated	Cisplatin results in decreased expression of LARS mRNA	5q32	A20427
Cisplatin	Approved Investigational	LHFP	10186	downregulated	Cisplatin results in decreased expression of LHFP mRNA	13q13.3-q14.11	A22204
Cisplatin	Approved Investigational	LHX2	9355	downregulated	Cisplatin results in decreased expression of LHX2 mRNA	9q33.3	A21499
Cisplatin	Approved Investigational	LIF	3976	upregulated	Cisplatin results in increased expression of LIF mRNA	22q12.2	A22212 A20662
Cisplatin	Approved Investigational	LIMK1	3984	downregulated	Cisplatin results in decreased expression of LIMK1 mRNA	7q11.23	A22204
Cisplatin	Approved Investigational	LPP	4026	downregulated	Cisplatin results in decreased expression of LPP mRNA	3q27.3-q28	A22204
Cisplatin	Approved Investigational	LRP1	4035	upregulated	Cisplatin results in increased expression of LRP1 mRNA	12q13.3	A22231
Cisplatin	Approved Investigational	LRRC47	57470	downregulated	Cisplatin results in decreased expression of LRRC47 mRNA	1p36.32	A21499
Cisplatin	Approved Investigational	LRRTM2	26045	upregulated	Cisplatin results in increased expression of LRRTM2 mRNA	5q31.2	A22204
Cisplatin	Approved Investigational	LSG1	55341	downregulated	Cisplatin results in decreased expression of LSG1 mRNA	3q29	A20660
Cisplatin	Approved Investigational	LTF	4057	downregulated	Cisplatin results in decreased expression of LTF mRNA	3p21.31	A22210
Cisplatin	Approved Investigational	LTN1	26046	downregulated	Cisplatin results in decreased expression of LTN1 mRNA	21q21.3	A20427
Cisplatin	Approved Investigational	LYN	4067	downregulated	Cisplatin results in decreased expression of LYN mRNA	8q12.1	A22211
Cisplatin	Approved Investigational	MAD1L1	8379	downregulated	Cisplatin results in decreased expression of MAD1L1 mRNA	7p22.3	A22212
Cisplatin	Approved Investigational	MALAT1	378938	upregulated	Cisplatin results in increased expression of MALAT1 mRNA	11q13.1	A22211
Cisplatin	Approved Investigational	MAML2	84441	downregulated	Cisplatin results in decreased expression of MAML2 mRNA	11q21	A22211
Cisplatin	Approved Investigational	MAN1A2	10905	downregulated	Cisplatin results in decreased expression of MAN1A2 mRNA	1p12	A20427
Cisplatin	Approved Investigational	MANF	7873	upregulated	Cisplatin results in increased expression of MANF mRNA	3p21.2	A22204
Cisplatin	Approved Investigational	MAP1LC3B	81631	upregulated	Cisplatin results in increased expression of MAP1LC3B mRNA	16q24.2	A22204
Cisplatin	Approved Investigational	MAP3K5	4217	downregulated	Cisplatin results in decreased expression of MAP3K5 mRNA	6q23.3	A22204
Cisplatin	Approved Investigational	MAP3K8	1326	downregulated	Cisplatin results in decreased expression of MAP3K8 mRNA	10p11.23	A20427
Cisplatin	Approved Investigational	MAP4K4	9448	downregulated	Cisplatin results in decreased expression of MAP4K4 mRNA	2q11.2	A22204
Cisplatin	Approved Investigational	MAPK12	6300	upregulated	Cisplatin results in increased expression of MAPK12 mRNA	22q13.33	A22211
Cisplatin	Approved Investigational	MAPKAP1	79109	downregulated	Cisplatin results in decreased expression of MAPKAP1 mRNA	9q33.3	A22204

Displaying entries 31776 - 31800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability